Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-065791
Filing Date
2016-05-16
Accepted
2016-05-16 17:09:23
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-Q 3-31-2016 form10q.htm 10-Q 400834
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7068
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 6850
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6080
  Complete submission text file 0001140361-16-065791.txt   2985430

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ast-20160331.xml EX-101.INS 344465
6 XBRL TAXONOMY EXTENSION SCHEMA ast-20160331.xsd EX-101.SCH 42711
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20160331_cal.xml EX-101.CAL 50546
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20160331_def.xml EX-101.DEF 164870
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20160331_lab.xml EX-101.LAB 507008
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20160331_pre.xml EX-101.PRE 281592
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36646 | Film No.: 161655039
SIC: 2836 Biological Products, (No Diagnostic Substances)